{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:43:59Z","timestamp":1793151839435,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s40264-024-01398-5","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T07:02:16Z","timestamp":1707894136000},"page":"419-438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Tacrolimus-Induced Neurotoxicity After Transplant: A Literature Review"],"prefix":"10.1007","volume":"47","author":[{"given":"Paige","family":"Verona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassidy","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Avorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzina Lo","family":"Re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Di Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Carollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7132-000X","authenticated-orcid":false,"given":"Alessio","family":"Provenzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"key":"1398_CR1","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/j.transproceed.2011.06.025","volume":"43","author":"C Ponticelli","year":"2011","unstructured":"Ponticelli C. Present and future of immunosuppressive therapy in kidney transplantation. Transpl Proc. 2011;43:2439\u201340.","journal-title":"Transpl Proc"},{"key":"1398_CR2","first-page":"CD008852","volume":"3","author":"L Penninga","year":"2012","unstructured":"Penninga L, Wettergren A, Chan AW, Steinbr\u00fcchel DA, Gluud C. Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients. Cochrane Database Syst Rev. 2012;3:CD008852.","journal-title":"Cochrane Database Syst Rev"},{"key":"1398_CR3","unstructured":"https:\/\/srtr.transplant.hrsa.gov\/annual_reports\/2021_ADR_Preview.aspx Accessed on 15 Mar 2023."},{"key":"1398_CR4","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2165\/00003088-199529060-00003","volume":"29","author":"R Venkataramanan","year":"1995","unstructured":"Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, Warty V, McMichael J, Lever J, Burckart G, Starzl T. Clinical pharmacokinetics of TAC. Clin Pharmacokinet. 1995;29:404\u201330.","journal-title":"Clin Pharmacokinet"},{"key":"1398_CR5","doi-asserted-by":"publisher","first-page":"21S","DOI":"10.1016\/S0041-1345(99)00788-5","volume":"31","author":"NA Undre","year":"1999","unstructured":"Undre NA, Stevenson P, Sch\u00e4fer A. Pharmacokinetics of TAC: clinically relevant aspects. Transpl Proc. 1999;31:21S-24S.","journal-title":"Transpl Proc"},{"key":"1398_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1432-2277.2000.tb01004.x","volume":"13","author":"WO Bechstein","year":"2000","unstructured":"Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int. 2000;13:313\u201326.","journal-title":"Transpl Int"},{"key":"1398_CR7","first-page":"3272","volume":"26","author":"R Morris","year":"1994","unstructured":"Morris R. Modes of action of FK506, cyclosporin A, and rapamycin. Transpl Proc. 1994;26:3272\u20135.","journal-title":"Transpl Proc"},{"issue":"48","key":"1398_CR8","doi-asserted-by":"publisher","first-page":"9156","DOI":"10.3748\/wjg.v19.i48.9156","volume":"19","author":"A Provenzani","year":"2013","unstructured":"Provenzani A, Santeusanio A, Mathis E, et al. Pharmacogenetic considerations for optimizing TAC dosing in liver and kidney transplant patients. World J Gastroenterol. 2013;19(48):9156\u201373.","journal-title":"World J Gastroenterol"},{"key":"1398_CR9","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.4049\/jimmunol.139.6.1797","volume":"139","author":"S Sawada","year":"1987","unstructured":"Sawada S, Suzuki G, Kawase Y, Takaku F. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol. 1987;139:1797\u2013803.","journal-title":"J Immunol"},{"key":"1398_CR10","unstructured":"TAC, In-Depth Answers. IBM Micromedex [database online]. Truven Health Analytics\/IBM Watson Health; 2022. https:\/\/www.micromedexsolutions.com. Accessed 16 Nov 2022."},{"issue":"3","key":"1398_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/pharmaceutics2030291","volume":"2","author":"K Marfo","year":"2010","unstructured":"Marfo K, Altshuler J, Lu A. TAC pharmacokinetic and pharmacogenomic differences between adults and pediatric solid organ transplant recipients. Pharmaceutics. 2010;2(3):291\u20139.","journal-title":"Pharmaceutics"},{"issue":"43","key":"1398_CR12","first-page":"623","volume":"30","author":"CE Staatz","year":"2012","unstructured":"Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of TAC in solid organ transplantation. Clin Pharmacokinet. 2012;30(43):623\u201353.","journal-title":"Clin Pharmacokinet"},{"key":"1398_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1442-2042.1995.tb00444.x","volume":"2","author":"H Ihara","year":"1995","unstructured":"Ihara H, Shinkuma D, Ichikawa Y, Nojima M, Nagano S, Ikoma F. Intra- and interindividual variation in the pharmacokinetics of TAC (FK506) in kidney transplant recipients\u2013importance of trough level as a practical indicator. Int J Urol. 1995;2:151\u20135.","journal-title":"Int J Urol"},{"key":"1398_CR14","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/00007691-199512000-00009","volume":"17","author":"WJ Jusko","year":"1995","unstructured":"Jusko WJ. Analysis of TAC (FK 506) in relation to therapeutic drug monitoring. Ther Drug Monit. 1995;17:596\u2013601.","journal-title":"Ther Drug Monit"},{"key":"1398_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.phrs.2018.02.016","volume":"130","author":"JB Woillard","year":"2018","unstructured":"Woillard JB, Saint-Marcoux F, Debord J, \u00c5sberg A. Pharmacokinetic models to assist the prescriber in choosing the best TAC dose. Pharmacol Res. 2018;130:316\u201321.","journal-title":"Pharmacol Res"},{"issue":"2","key":"1398_CR16","first-page":"170","volume":"8","author":"D Anghel","year":"2013","unstructured":"Anghel D, Tanasescu R, Campeanu A, Lupescu I, Podda G, Bajenaru O. Neurotoxicity of immunosuppressive therapies in organ transplantation. Maedica (Bucur). 2013;8(2):170\u20135.","journal-title":"Maedica (Bucur)."},{"issue":"1","key":"1398_CR17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12883-021-02479-z","volume":"21","author":"B Jin","year":"2021","unstructured":"Jin B, Kim GY, Cheon SM. TAC-induced neurotoxicity from bipolar disorder to status epilepticus under the therapeutic serum level: a case report. BMC Neurol. 2021;21(1):448. https:\/\/doi.org\/10.1186\/s12883-021-02479-z.","journal-title":"BMC Neurol"},{"issue":"11","key":"1398_CR18","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1053\/jlts.2001.27475","volume":"7","author":"E Wijdicks","year":"2001","unstructured":"Wijdicks E. Neurotoxicity of immunosuppressive drugs. Liver Transpl. 2001;7(11):937\u201342. https:\/\/doi.org\/10.1053\/jlts.2001.27475.","journal-title":"Liver Transpl"},{"issue":"23","key":"1398_CR19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.12659\/AOT.910298.PMID:30150606;PMCID:PMC6248284","volume":"28","author":"JR Tatreau","year":"2018","unstructured":"Tatreau JR, Laughon SL, Kozlowski T. Catatonia after liver transplantation. Ann Transpl. 2018;28(23):608\u201314. https:\/\/doi.org\/10.12659\/AOT.910298.PMID:30150606;PMCID:PMC6248284.","journal-title":"Ann Transpl"},{"issue":"20","key":"1398_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100932","volume":"16","author":"KK Gokoffski","year":"2020","unstructured":"Gokoffski KK, Patel VR. A case of reversible toxic optic neuropathy from TAC (FK506). Am J Ophthalmol Case Rep. 2020;16(20): 100932. https:\/\/doi.org\/10.1016\/j.ajoc.2020.100932.","journal-title":"Am J Ophthalmol Case Rep."},{"key":"1398_CR21","doi-asserted-by":"publisher","first-page":"9998205","DOI":"10.1155\/2021\/9998205","volume":"2021","author":"JA Rivillas","year":"2021","unstructured":"Rivillas JA, Galindo-Coral S, Arias-Mora F, Lopez-Ponce de Leon JD, Florez-Alarc\u00f3n NA, Olaya-Rojas P, Gomez-Mesa JE. Posterior reversible encephalopathy syndrome associated with TAC in cardiac transplantation. Case Rep Cardiol. 2021;2021:9998205. https:\/\/doi.org\/10.1155\/2021\/9998205.","journal-title":"Case Rep Cardiol"},{"issue":"2","key":"1398_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/s0887-8994(02)00502-7","volume":"28","author":"DK Sokol","year":"2003","unstructured":"Sokol DK, Molleston JP, Filo RS, Van Valer J, Edwards-Brown M. TAC (FK506)-induced mutism after liver transplant. Pediatr Neurol. 2003;28(2):156\u20138. https:\/\/doi.org\/10.1016\/s0887-8994(02)00502-7.","journal-title":"Pediatr Neurol"},{"key":"1398_CR23","doi-asserted-by":"publisher","DOI":"10.6002\/ect.2020.0278","author":"F Aksoy","year":"2021","unstructured":"Aksoy F, Dundar HZ, Bican Demir A, Kiyici M, Kaya E. Myelitis after liver transplant: a case report. Exp Clin Transplant. 2021. https:\/\/doi.org\/10.6002\/ect.2020.0278. (Epub ahead of print).","journal-title":"Exp Clin Transplant"},{"key":"1398_CR24","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1136\/bcr-2013-201099","volume":"23","author":"BH Eidelman","year":"1991","unstructured":"Eidelman BH, Abu-Elmagd K, Wilson J, et al. Neurologic complications of FK 506. Transpl Proc. 1991;23:3175\u20138. https:\/\/doi.org\/10.1136\/bcr-2013-201099.","journal-title":"Transpl Proc"},{"key":"1398_CR25","doi-asserted-by":"publisher","first-page":"S592","DOI":"10.1097\/01.tp.0000543479.97208.46","volume":"102","author":"P Fontova","year":"2018","unstructured":"Fontova P, Rigo-Bonnin R, Vidal-Alabr\u00f3 A, Cerezo G, Bestard O, Melilli E, et al. Extended release tacrolimus (LCP-TAC) prolongs calcineurin activity inhibition during drug doses intervals. Transplantation. 2018;102:S592\u20133.","journal-title":"Transplantation"},{"issue":"4","key":"1398_CR26","doi-asserted-by":"publisher","first-page":"S502","DOI":"10.1016\/j.healun.2020.01.102","volume":"39","author":"M Kim","year":"2020","unstructured":"Kim M, Givertz MM, Stewart GC, Page DS, Woodcome EL, Mehra MR. Efficacy and safety of LCP-tacrolimus (Envarsus XR\u00ae) conversion therapy in heart transplantation. J Heart Lung Transpl. 2020;39(4):S502.","journal-title":"J Heart Lung Transpl"},{"issue":"8","key":"1398_CR27","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/MEG.0000000000002172","volume":"33","author":"D Choi","year":"2021","unstructured":"Choi D, Thaker S, West-Thielke P, et al. Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipients. Eur J Gastroenterol Hepatol. 2021;33(8):1124\u20138. https:\/\/doi.org\/10.1097\/MEG.0000000000002172.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10 Supplement","key":"1398_CR28","doi-asserted-by":"publisher","first-page":"4.072","DOI":"10.1212\/WNL.82.10_supplement.P4.072","volume":"82","author":"J Morgan","year":"2014","unstructured":"Morgan J, Langone A, Nigro V, Mehta S, Sethi K. Tacrolimus-induced tremor: switching from immediate-release (IR-TAC) to LCP-tacro extended-release tacrolimus (LCPT) reduces tremor and improves quality of life. Neurology. 2014;82(10 Supplement):4.072.","journal-title":"Neurology"},{"key":"1398_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/00007890-200002270-00001","volume":"69","author":"N Singh","year":"2000","unstructured":"Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation. 2000;69:467\u201372.","journal-title":"Transplantation"},{"key":"1398_CR30","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1432-2277.2011.01280.x","volume":"24","author":"D Balderramo","year":"2011","unstructured":"Balderramo D, Prieto J, C\u00e1rdenas A, et al. Hepatic encephalopathy and post-transplant hyponatremia predict early calcineurin inhibitor-induced neurotoxicity after liver transplantation. Transpl Int. 2011;24:812\u20139.","journal-title":"Transpl Int"},{"issue":"6","key":"1398_CR31","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/lt.21427","volume":"14","author":"A DiMartini","year":"2008","unstructured":"DiMartini A, Fontes P, Dew MA, et al. Age, Model for End-stage Liver Disease score, and organ functioning predict posttransplant TAC neurotoxicity. Liver Transpl. 2008;14(6):815\u201322.","journal-title":"Liver Transpl"},{"key":"1398_CR32","doi-asserted-by":"publisher","first-page":"e935938-1","DOI":"10.12659\/AOT.935938","volume":"27","author":"DA Alissa","year":"2022","unstructured":"Alissa DA, Alkortas D, Alsebayel M, et al. TAC-induced neurotoxicity in early post-liver transplant Saudi patients: incidence and risk factors. Ann Transpl. 2022;27:e935938-1-e935938-9.","journal-title":"Ann Transpl"},{"issue":"9","key":"1398_CR33","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1212\/01.wnl.0000089487.42870.c6","volume":"61","author":"MB Lewis","year":"2003","unstructured":"Lewis MB, Howdle PD. Neurologic complications of liver transplantation in adults. Neurology. 2003;61(9):1174\u20138. https:\/\/doi.org\/10.1212\/01.wnl.0000089487.42870.c6.","journal-title":"Neurology"},{"key":"1398_CR34","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1097\/TP.0000000000002750","volume":"103","author":"A Lu\u00e9","year":"2019","unstructured":"Lu\u00e9 A, Martinez E, Navarro M, et al. Donor age predicts calcineurin inhibitor induced neurotoxicity after liver transplantation. Transplantation. 2019;103:e211\u20135. https:\/\/doi.org\/10.1097\/TP.0000000000002750.","journal-title":"Transplantation"},{"issue":"2","key":"1398_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00007890-199405820-00006","volume":"58","author":"AR Mueller","year":"1994","unstructured":"Mueller AR, Platz KP, Bechstein WO, et al. Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation. 1994;58(2):155\u201370.","journal-title":"Transplantation"},{"issue":"4","key":"1398_CR36","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1053\/j.gastro.2006.02.017","volume":"130","author":"MC Londo\u00f1o","year":"2006","unstructured":"Londo\u00f1o MC, Guevara M, Rimola A, et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology. 2006;130(4):1135\u201343. https:\/\/doi.org\/10.1053\/j.gastro.2006.02.017.","journal-title":"Gastroenterology"},{"key":"1398_CR37","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.3748\/wjg.v22.i24.5548","volume":"22","author":"SY Wu","year":"2016","unstructured":"Wu SY, Chen TW, Feng AC, Fan HL, Hsieh CB, Chung KP. Comprehensive risk assessment for early neurologic complications after liver transplantation. World J Gastroenterol. 2016;22:5548\u201357. https:\/\/doi.org\/10.3748\/wjg.v22.i24.5548.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"1398_CR38","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/jlts.2001.28964","volume":"7","author":"Y Sakamoto","year":"2001","unstructured":"Sakamoto Y, Makuuchi M, Harihara Y, Imamura H, Sato H. Higher intracerebral concentration of TAC after intermittent than continuous administration to rats. Liver Transpl. 2001;7(12):1071\u20136. https:\/\/doi.org\/10.1053\/jlts.2001.28964.","journal-title":"Liver Transpl"},{"issue":"11","key":"1398_CR39","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/lt.22383","volume":"17","author":"G Vizzini","year":"2011","unstructured":"Vizzini G, Asaro M, Miraglia R, et al. Changing picture of central nervous system complications in liver transplant recipients. Liver Transpl. 2011;17(11):1279\u201385. https:\/\/doi.org\/10.1002\/lt.22383.","journal-title":"Liver Transpl"},{"issue":"6","key":"1398_CR40","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1399-0012.2009.01181.x","volume":"24","author":"M Yanagimachi","year":"2010","unstructured":"Yanagimachi M, Naruto T, Tanoshima R, et al. Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation. Clin Transpl. 2010;24(6):855\u201361.","journal-title":"Clin Transpl"},{"issue":"4","key":"1398_CR41","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/00007890-200208270-00024","volume":"74","author":"A Yamauchi","year":"2002","unstructured":"Yamauchi A, Ieiri I, Kataoka Y, Tanabe M, Nishizaki T, Oishi R, Higuchi S, Otsubo K, Sugimachi K. Neurotoxicity induced by TAC after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. Transplantation. 2002;74(4):571\u20132.","journal-title":"Transplantation"},{"issue":"23","key":"1398_CR42","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0024-3205(00)00554-3","volume":"66","author":"S Kochi","year":"2000","unstructured":"Kochi S, Takanaga H, Matsuo H, et al. Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin a and TAC. Life Sci. 2000;66(23):2255\u201360.","journal-title":"Life Sci"},{"issue":"912","key":"1398_CR43","first-page":"849","volume":"76","author":"KJ Ahn","year":"2014","unstructured":"Ahn KJ, Lee JW, Hahn ST, et al. Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity. Br J Radiol. 2014;76(912):849\u2013943.","journal-title":"Br J Radiol"},{"issue":"2020","key":"1398_CR44","first-page":"1015385","volume":"14","author":"E Tinelli","year":"2020","unstructured":"Tinelli E, Locuratolo N, Pierallini A, et al. Diffusion MRI findings in encephalopathy induced by immunosuppressive therapy after liver transplantation. Case Rep Med. 2020;14(2020):1015385.","journal-title":"Case Rep Med"},{"issue":"1","key":"1398_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.brainres.2006.11.037","volume":"1133","author":"T Takadera","year":"2007","unstructured":"Takadera T, Ohyashiki T. Caspase-dependent apoptosis induced by calcineurin inhibitors was prevented by glycogen synthase kinase-3 inhibitors in cultured rat cortical cells. Brain Res. 2007;1133(1):20\u20136.","journal-title":"Brain Res"},{"issue":"11","key":"1398_CR46","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.1007\/s12035-021-02499-3","volume":"58","author":"YJ Shin","year":"2021","unstructured":"Shin YJ, Lim SW, Cui S, et al. TAC decreases cognitive function by impairing hippocampal synaptic balance: a possible role of Klotho. Mol Neurobiol. 2021;58(11):5954\u201370.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1398_CR47","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1084\/jem.176.3.751","volume":"176","author":"FJ Dumont","year":"1992","unstructured":"Dumont FJ, Staruch MJ, Koprak SL, et al. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. J Exp Med. 1992;176(3):751\u201360.","journal-title":"J Exp Med"},{"issue":"7","key":"1398_CR48","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2174\/0929867003374723","volume":"7","author":"FJ Dumont","year":"2000","unstructured":"Dumont FJ. FK506, an immunosuppressant targeting calcineurin function. Curr Med Chem. 2000;7(7):731\u201348.","journal-title":"Curr Med Chem"},{"issue":"10","key":"1398_CR49","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1248\/bpb.31.1911","volume":"31","author":"CA Quezada","year":"2008","unstructured":"Quezada CA, Garrido WX, Gonzale-Oyarzun MA, et al. Effect of TAC on activity and expression of p-glycoprotein and ATP-binding cassette transporter A5 (ABCA5) proteins in hematoencephalic barrier cells. Biol Pharm Bull. 2008;31(10):1911\u20136.","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"1398_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.12701\/yujm.2019.00108","volume":"36","author":"JH Seong","year":"2019","unstructured":"Seong JH, Park WY, Paek JH, et al. Impact of calcineurin inhibitors on rat glioma cells viability. Yeungnam Univ J Med. 2019;36(2):105\u20138.","journal-title":"Yeungnam Univ J Med."},{"key":"1398_CR51","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1016\/j.transproceed.2008.08.033","volume":"40","author":"KB Jin","year":"2008","unstructured":"Jin KB, Choi HJ, Kim HT, et al. The production of reactive oxygen species in TAC-treated glial cells. Transpl Proc. 2008;40:2680\u20131.","journal-title":"Transpl Proc"},{"issue":"6","key":"1398_CR52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10565-013-9263-0","volume":"29","author":"M Palacin","year":"2013","unstructured":"Palacin M, Coto E, Llobet L, et al. FK506 affects mitochondrial protein synthesis and oxygen consumption in human cells. Cell Biol Toxicol. 2013;29(6):407\u201314.","journal-title":"Cell Biol Toxicol"},{"issue":"5","key":"1398_CR53","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0024-3205(98)00284-7","volume":"63","author":"R Zini","year":"1998","unstructured":"Zini R, Simon N, Morin C, et al. TAC decrease in vitro oxidative phosphorylation of mitochondria from rat forebrain. Life Sci. 1998;63(5):357\u201368.","journal-title":"Life Sci"},{"key":"1398_CR54","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1111\/ajt.12324","volume":"13","author":"R Arnold","year":"2013","unstructured":"Arnold R, Pussell BA, Pianta TJ, et al. Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients. Am J Transpl. 2013;13:2426\u201332.","journal-title":"Am J Transpl"},{"key":"1398_CR55","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5301\/jn.5000174","volume":"25","author":"EJ Hoorn","year":"2012","unstructured":"Hoorn EJ, Walsh SB, McCormick JA, et al. Pathogenesis of calcineurin inhibitor-induced hypertension. J Nephrol. 2012;25:269\u201375.","journal-title":"J Nephrol"},{"key":"1398_CR56","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s40620-020-00956-1","volume":"34","author":"I Faravelli","year":"2021","unstructured":"Faravelli I, Velardo D, Podest\u00e0 MA, et al. Immunosuppression-related neurological disorders in kidney transplantation. J Nephrol. 2021;34:539\u201355.","journal-title":"J Nephrol"},{"issue":"3","key":"1398_CR57","doi-asserted-by":"publisher","first-page":"205","DOI":"10.14503\/THIJ-15-5007","volume":"44","author":"A Kapoor","year":"2017","unstructured":"Kapoor A, Birks E, Lenneman A, McCants K. Posterior reversible encephalopathy syndrome after heart transplantation: diagnosis and immunosuppressive therapy. Tex Heart Inst J. 2017;44(3):205\u20138. https:\/\/doi.org\/10.14503\/THIJ-15-5007.","journal-title":"Tex Heart Inst J"},{"issue":"2","key":"1398_CR58","first-page":"139","volume":"9","author":"Y Umeda","year":"2011","unstructured":"Umeda Y, Matsuda H, Sadamori H, et al. Leukoencephalopathy syndrome after living-donor liver transplantation. Exp Clin Transplant. 2011;9(2):139\u201344.","journal-title":"Exp Clin Transplant"},{"issue":"13","key":"1398_CR59","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.12998\/wjcc.v8.i13.2870.PMID:32742997;PMCID:PMC7360704","volume":"8","author":"JF Liu","year":"2020","unstructured":"Liu JF, Shen T, Zhang YT. Posterior reversible encephalopathy syndrome and heart failure TAC-induced after liver transplantation: a case report. World J Clin Cases. 2020;8(13):2870\u20135. https:\/\/doi.org\/10.12998\/wjcc.v8.i13.2870.PMID:32742997;PMCID:PMC7360704.","journal-title":"World J Clin Cases."},{"issue":"8","key":"1398_CR60","first-page":"387","volume":"60","author":"N Ueda","year":"2014","unstructured":"Ueda N, Kawamura M, Nakazawa S, et al. Posterior reversible encephalopathy syndrome (PRES) after kidney transplantation: a case report. Hinyokika Kiyo. 2014;60(8):387\u201392 (Japanese).","journal-title":"Hinyokika Kiyo"},{"issue":"14","key":"1398_CR61","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003173","volume":"95","author":"T Song","year":"2016","unstructured":"Song T, Rao Z, Tan Q, et al. Calcineurin inhibitors associated posterior reversible encephalopathy syndrome in solid organ transplantation: report of 2 cases and literature review. Medicine (Baltimore). 2016;95(14): e3173. https:\/\/doi.org\/10.1097\/MD.0000000000003173.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"1398_CR62","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.transproceed.2012.06.027","volume":"44","author":"L Rosso","year":"2012","unstructured":"Rosso L, Nosotti M, Mendogni P, et al. Lung transplantation and posterior reversible encephalopathy syndrome: a case series. Transpl Proc. 2012;44(7):2022\u20135. https:\/\/doi.org\/10.1016\/j.transproceed.2012.06.027.","journal-title":"Transpl Proc"},{"key":"1398_CR63","doi-asserted-by":"publisher","first-page":"bcr2013201099","DOI":"10.1136\/bcr-2013-201099","volume":"2013","author":"G Wu","year":"2013","unstructured":"Wu G, Weng FL, Balaraman V. Tacrolimus-induced encephalopathy and polyneuropathy in a renal transplant recipient. BMJ Case Rep. 2013;2013:bcr2013201099. https:\/\/doi.org\/10.1136\/bcr-2013-201099.","journal-title":"BMJ Case Rep"},{"issue":"2","key":"1398_CR64","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4103\/0022-3859.81871","volume":"57","author":"A Jain","year":"2011","unstructured":"Jain A, Mathew PJ, Modi M, et al. Unilateral common peroneal nerve palsy following renal transplantation: a case report of TAC neurotoxicity. J Postgrad Med. 2011;57(2):126\u20138. https:\/\/doi.org\/10.4103\/0022-3859.81871.","journal-title":"J Postgrad Med"},{"issue":"10","key":"1398_CR65","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1016\/j.transproceed.2007.06.088","volume":"39","author":"S Bhagavati","year":"2007","unstructured":"Bhagavati S, Maccabee P, Muntean E, Sumrani NB. Chronic sensorimotor polyneuropathy associated with tacrolimus immunosuppression in renal transplant patients: case reports. Transpl Proc. 2007;39(10):3465\u20137. https:\/\/doi.org\/10.1016\/j.transproceed.2007.06.088.","journal-title":"Transpl Proc"},{"issue":"3","key":"1398_CR66","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.clineuro.2007.10.014","volume":"110","author":"A De Weerdt","year":"2008","unstructured":"De Weerdt A, Claeys KG, De Jonghe P, et al. Tacrolimus-related polyneuropathy: case report and review of the literature. Clin Neurol Neurosurg. 2008;110(3):291\u20134. https:\/\/doi.org\/10.1016\/j.clineuro.2007.10.014. (Epub 2007 Dec 4).","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"1398_CR67","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12883-018-1052-1","volume":"18","author":"K Gmitterov\u00e1","year":"2018","unstructured":"Gmitterov\u00e1 K, Min\u00e1r M, \u017digrai M, et al. TAC-induced parkinsonism in a patient after liver transplantation\u2014case report. BMC Neurol. 2018;18(1):44. https:\/\/doi.org\/10.1186\/s12883-018-1052-1.","journal-title":"BMC Neurol"},{"issue":"4","key":"1398_CR68","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1592\/phco.24.5.532.33357","volume":"24","author":"WA Prescott Jr","year":"2004","unstructured":"Prescott WA Jr, Callahan BL, Park JM. TAC toxicity associated with concomitant metoclopramide therapy. Pharmacotherapy. 2004;24(4):532\u20137. https:\/\/doi.org\/10.1592\/phco.24.5.532.33357.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"1398_CR69","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40842-016-0019-7","volume":"26","author":"KK Cheung","year":"2016","unstructured":"Cheung KK, Senior PA. TAC toxicity in islet transplantation due to interaction with macrolides. Clin Diabetes Endocrinol. 2016;26(2):2. https:\/\/doi.org\/10.1186\/s40842-016-0019-7.","journal-title":"Clin Diabetes Endocrinol."},{"issue":"4","key":"1398_CR70","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/ckj\/sfs067","volume":"5","author":"D Renard","year":"2012","unstructured":"Renard D, Gauthier T, Venetz JP, et al. Late onset tacrolimus-induced life-threatening polyneuropathy in a kidney transplant recipient patient. Clin Kidney J. 2012;5(4):323\u20136. https:\/\/doi.org\/10.1093\/ckj\/sfs067.","journal-title":"Clin Kidney J"},{"issue":"4","key":"1398_CR71","first-page":"60","volume":"12","author":"T Antychin","year":"2021","unstructured":"Antychin T, Zarowski JA, Verplancke V, et al. Reversible Calcineurin inhibitor-associated sensorimotor polyneuropathy in a lung transplant recipient: a case report. Int J Organ Transpl Med. 2021;12(4):60\u20134.","journal-title":"Int J Organ Transpl Med."},{"issue":"9","key":"1398_CR72","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1097\/TP.0b013e31826dde21","volume":"94","author":"X Shao","year":"2012","unstructured":"Shao X, He Z, Tang L, Gao L. Tacrolimus-associated ischemic optic neuropathy and posterior reversible encephalopathy syndrome after small bowel transplantation. Transplantation. 2012;94(9):e58-60. https:\/\/doi.org\/10.1097\/TP.0b013e31826dde21.","journal-title":"Transplantation"},{"issue":"3","key":"1398_CR73","first-page":"180","volume":"7","author":"C Heidenhain","year":"2009","unstructured":"Heidenhain C, Puhl G, Neuhaus P. Late fulminant posterior reversible encephalopathy syndrome after liver transplant. Exp Clin Transplant. 2009;7(3):180\u20133.","journal-title":"Exp Clin Transplant"},{"issue":"7","key":"1398_CR74","first-page":"1251","volume":"21","author":"PJ Oliverio","year":"2000","unstructured":"Oliverio PJ, Restrepo L, Mitchell SA, et al. Reversible TAC-induced neurotoxicity isolated to the brain stem. AJNR Am J Neuroradiol. 2000;21(7):1251\u20134.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"1398_CR75","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1212\/WNL.0000000000002467","volume":"86","author":"A Saadi","year":"2016","unstructured":"Saadi A, Schmahmann JD. Pearls & Oy-sters: TAC neurotoxicity presenting as an isolated brainstem lesion. Neurology. 2016;86(11):e109\u201311. https:\/\/doi.org\/10.1212\/WNL.0000000000002467.","journal-title":"Neurology"},{"issue":"18","key":"1398_CR76","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12991-019-0242-6","volume":"5","author":"EH Seo","year":"2019","unstructured":"Seo EH, Kim SG, Cho YS, Yoon HJ. Tuberculum sellae meningioma with possible TAC neurotoxicity manifesting as manic-like psychosis after kidney transplantation. Ann Gen Psychiatry. 2019;5(18):18. https:\/\/doi.org\/10.1186\/s12991-019-0242-6.","journal-title":"Ann Gen Psychiatry"},{"issue":"4","key":"1398_CR77","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s40120-023-00479-4","volume":"12","author":"JB Layton","year":"2023","unstructured":"Layton JB, Ritchey ME, Huang Z, et al. Intravenous immunoglobulin initiation in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a US claims-based cohort study. Neurol Ther. 2023;12(4):1171\u201386. https:\/\/doi.org\/10.1007\/s40120-023-00479-4. (Epub 2023 May 17).","journal-title":"Neurol Ther."},{"issue":"11","key":"1398_CR78","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1093\/brain\/awaa265","volume":"143","author":"F Eftimov","year":"2020","unstructured":"Eftimov F, Lucke IM, Querol LA, Rajabally YA, Verhamme C. Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy. Brain. 2020;143(11):3214\u201324. https:\/\/doi.org\/10.1093\/brain\/awaa265.","journal-title":"Brain"},{"issue":"13","key":"1398_CR79","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5334\/tohm.725","volume":"30","author":"A Wagle Shukla","year":"2023","unstructured":"Wagle Shukla A, Lunny C, Hisham I, et al. Phenomenology and physiology of tacrolimus induced tremor. Tremor Other Hyperkinet Mov (N Y). 2023;30(13):2. https:\/\/doi.org\/10.5334\/tohm.725.","journal-title":"Tremor Other Hyperkinet Mov (N Y)."},{"issue":"9","key":"1398_CR80","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1016\/j.apmr.2007.06.540","volume":"88","author":"T Yoon","year":"2007","unstructured":"Yoon T, Kelly BM, Hornyak J. Poster 32: use of propranolol for treating TAC-induced tremors: a case report. Arch Phys Med Rehabil. 2007;88(9):E19.","journal-title":"Arch Phys Med Rehabil"},{"key":"1398_CR81","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1056\/NEJM200108093450606","volume":"345","author":"CM Filley","year":"2001","unstructured":"Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med. 2001;345:425\u201332.","journal-title":"N Engl J Med"},{"key":"1398_CR82","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/250472","author":"JA Bourgeois","year":"2014","unstructured":"Bourgeois JA, Hategan A. Immunosuppressant-associated neurotoxicity responding to olanzapine. Case Rep Psychiatry. 2014. https:\/\/doi.org\/10.1155\/2014\/250472.","journal-title":"Case Rep Psychiatry."},{"key":"1398_CR83","doi-asserted-by":"publisher","DOI":"10.1576\/CCRR.1000187","author":"S Jain","year":"2015","unstructured":"Jain S, Liao YH, Li D. TAC induced mania with psychosis- a case report. Clin Case Rep Rev. 2015. https:\/\/doi.org\/10.1576\/CCRR.1000187.","journal-title":"Clin Case Rep Rev."},{"key":"1398_CR84","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-023-06760-6","author":"A Provenzani","year":"2023","unstructured":"Provenzani A, Re VL. Tacrolimus-induced akinetic mutism and persistent dysarthria following orthotopic liver transplantation. Neurol Sci. 2023. https:\/\/doi.org\/10.1007\/s10072-023-06760-6.","journal-title":"Neurol Sci"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-024-01398-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-024-01398-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-024-01398-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T12:19:17Z","timestamp":1713183557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-024-01398-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1398"],"URL":"https:\/\/doi.org\/10.1007\/s40264-024-01398-5","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,14]]},"assertion":[{"value":"18 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors received no financial support for the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"JE, KH, and PV performed the literature review and wrote the first draft of the manuscript. FA, VL, RD, AC, and HJ revised the subsequent versions. AP contributed to the study conceptualization, manuscript writing, and project oversight. All authors read and approved the final version of the manuscript prior to submission.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}